SupremeCourt

  • Subscribe to our RSS feed.
  • Twitter
  • StumbleUpon
  • Reddit
  • Facebook
  • Digg

Monday, May 27, 2013

Comparative Advertising: Reckitt Benckiser trumps Hindustan Lever Ltd again

Posted on 1:42 PM by Unknown
The Delhi High Court in yet another order granted Reckitt Benckiser an interim injunction against Hindustan Lever Ltd (HUL). This is the second order granted in favour of Reckitt Benckiser against HUL recently (read the first one here).

The dispute may be traced back to Reckitt Benckiser’s (plaintiff’s)TV commercial and print campaign which compared the germ killing capabilities of its product Dettol Healthy Kitchen and HUL’s (defendant) Vim Liquid. These advertisements supposedly contained truthful statements about the germ killing capabilities of the two competing products. The defendant proceeded filed a suit against the plaintiff for disparaging advertisement before the Calcutta High Court. However, the Court passed a consent order in this matter allowing the plaintiff to continue with the impugned television advertisement subject to small variations.

The present dispute arose out of the following facts: The plaintiff alleged that in retaliation to the previous Calcutta HC order, the defendant came out with an advertisement published in the Sunday Times Edition in which the defendant disparaged the plaintiff and its brand Dettol. It contended that in the advertisement, the defendant maliciously equated its product to a “Harsh Antiseptic”. The question asked in the initial portion of the advertisement was:

“A Harsh Antiseptic or the power of 100 lemons – which one would you choose to clean your child’s tiffin?”

The plaintiff contended that the above question directly indicated the brand Dettol, and also misrepresented to consumers that plaintiff’s Dettol antiseptic liquid and Dettol Healthy Kitchen have the same ingredients. Furthermore, the advertisement went on to ask:

“An Antiseptic is for cleaning wounds and floors. Would you use to clean the utensils your family eats from?”

The plaintiff again contended that this particular question renders the target brand to be that of Dettol’s Antiseptic Liquid, which is used for cleaning wounds and floors. The advertisement thereafter mentioned with a disclaimer in fine print:

“NO ONE REMOVES GREASE BETTER*; NO ONE REMOVES GERMS BETTER*”

The defendant submitted that the campaign did not make any reference to the plaintiff’s products and only sought to inform the consumers that harsh antiseptics were not fit for cleaning utensils. It contended that the plaintiffs had themselves admitted that the antiseptics did not fall in the ‘harsh ‘category, and thus construing it as a reference to their brand was baseless and frivolous . Moreover, the plaintiff did not file any conclusive evidence to show that the overwhelming majority of consumers associate the term “harsh antiseptic” in reference to the plaintiff’s products. Further, HUL submitted that it was entitled to puff its products; and that the plaintiff was being hypersensitive to such puffery. It was also claimed that the campaign was purely intended to promote superiority of their product over other competitors, which was within their fundamental right of free speech and expression. The advertisement was also in line with the principles as postulated by Advertising Standards Council of India (ASCI). Thus, the defendants denied disparagement of the plaintiff’s product.

Whether the advertisements were disparaging -


Justice M L Mehta decided that prima facie the advertisement targeted the plaintiff’s brand Dettol and its product Dettol Healthy Kitchen. The Court relied on Dabur India Ltd v. Colortek Meghalaya Pvt. Ltd& ors; De Beers Abrasive; and Pepsi Co. Inc. &Ors vs. Hindustan Coca cola Ltd. & Anr, and reiterated the four pronged test for disparagement laid down in them:

(i) An advertisement is commercial speech and is protected by Article 19(1) (a) of the Constitution

(ii) An advertisement must not be false, misleading, unfair or deceptive.

(iii) There grey areas need not necessarily be taken as serious representation of facts but only as glorifying one’s product.

(iv) While glorifying its product, an advertiser may not denigrate or disparage a rival product.

The Division Bench in the Dabur-Colortek case had held that while hyped-up advertising may be permissible, it cannot transgress the grey areas of permissible assertion, and if it does so, it must have some reasonable factual basis for the assertion made and that it is not permissible for anybody to make an off-the-cuff or unsubstantiated claim that his goods are the best in the world or that his goods are better than that of a rival. Based on these principles, in the instant case the Court held that the defendant's claims did not fall with the purview of permissive comparative advertising.

The Court also stated that it is common knowledge that the plaintiff’s brand Dettol is synonymous with the term antiseptic in the FMCG market in India. In support it mentioned an older Delhi HC decision[1] wherein it was observed that the public carried an impression in their minds that all Dettol products are antiseptic. Further, it was held that the usage of the term ‘harsh antiseptic’ actually referred to an antiseptic (and not a particular brand) which is harsh, wherein the term ‘harsh’ is used as an adjective. Thus, the ad made a direct link between the antiseptic and Kitchen liquid, and connoted a similar strong effect of both liquids. Media reports in print and on social media also suggested that consumers drew the above-mentioned inferences. 

Thus, the Court passed an interim order restraining the defendant to the extent indicated above from publishing the impugned advertisement or any other similar advertisement or depiction aimed at disparaging the goodwill and reputation of the plaintiff’ s brand.

[1] Reckitt Benckiser (India) Ltd. v. Hindustan Unilever Ltd., 2008 (38) PTC 139 (Del.)
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted in Comparative Advertising, Trademark | No comments
Newer Post Older Post Home

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Posts

  • IPAB on Payyannur Ring
    [*S lightly long post] Background: The Intellectual Property Appellate Board (“ IPAB ”), in its recent order in SubhashJewellery v. Payyan...
  • Guest Post: Intermediary liability in defamation cases - Parle, Mouthshut & Visakha cases to clarify the law
    Chaitanya Ramachandran, who has blogged for us previously over here and here , has sent us this excellent guest post analyzing the extent of...
  • Delhi HC rejects the "Hot News" Doctrine: A Summary
    The applicability of the Hot News doctrine was rejected recently in a landmark ruling delivered by Justice Bhat of the Delhi HC. This post i...
  • IP Research Assistant position at IIT, Madras
    Feroz Ali Khader, MHRD IP Chair at the Indian Institute of Technology (IIT) Madras, is looking for research assistants to work on various is...
  • Satyajit Ray's sketches and copyright controversies
    A copyright row appears to have started between the Satyajit Ray Society and the Delhi Art Gallery, that is organising a countrywide exhibit...
  • Dorling Kindersley v. Sanguine Technical Publishers
    A recent Delhi High Court order passed on 21 January, 2013  with respect to copyright licensing has come to our notice. An analysis of the j...
  • Call for Papers: IIT Bombay and MHRD jointly announce the 2nd International Conference on Management of Intellectual Property and Strategy
    The readers may be interested to know that the Shailesh J. Mehta School of Management of IIT Bombay is geared up to host, in collaboration w...
  • SpicyIP Tidbit: ALCS August Distribution
    In the UK, the Authors' Licensing and Collecting Society is an organization run and owned by writers that collects money due to its mem...
  • Aaron Swartz, RIP
    See Cory Doctorow's eulogy here Some of us in India may not have heard of Aaron Swartz, a 26 year old activist who was heavily involved ...
  • Thalappakatti biryani trademark row
    The southern district of Dindigal in Tamil Nadu occupies a special place in the hearts of biryani lovers. In the late 1950s, one Nagasamy N...

Categories

  • 126 (1)
  • 3(d) (4)
  • 3(f) (1)
  • 3(i) (1)
  • 3(k) (2)
  • Academic Writing (1)
  • access (10)
  • access to food (1)
  • access to health (3)
  • AIA (1)
  • AIDS/HIV (3)
  • Antitrust (2)
  • Bajaj v LML (1)
  • Basmati Row (2)
  • Biological Diversity (5)
  • Biologics (2)
  • biopiracy (4)
  • biotech (7)
  • Bollywood (25)
  • Broadcasters Rights (5)
  • Budget (1)
  • business method patent (2)
  • Call for papers (2)
  • Cipla (2)
  • Comparative Advertising (4)
  • Competition law (8)
  • Compulsory Licensing (27)
  • condonation of delay (1)
  • Conference (4)
  • Constitution (12)
  • Contracts (1)
  • Controller's decisions (8)
  • Copyright (112)
  • Copyright Amendment Bill 2010 (23)
  • copyright board (4)
  • Copyright Exceptions (6)
  • copyright office (1)
  • Copyright Rules (2013) (5)
  • Copyright Societies (9)
  • Counterfeiting (1)
  • creativity (1)
  • Cross Retaliation (1)
  • csir (4)
  • d (1)
  • D.U. Photocopy Case (16)
  • Darjeeling Tea (3)
  • Data Exclusivity (2)
  • Database (1)
  • DCGI (2)
  • decompilation (2)
  • defamation (9)
  • Designs (3)
  • Designs Act (3)
  • Differential Pricing (2)
  • Dilution (1)
  • Disabilities (3)
  • Disability (2)
  • DMCA (2)
  • Doha Declaration (1)
  • Domain Names (2)
  • Draft Policy of the Indian Government (2)
  • DRM (1)
  • Drug Regulation (7)
  • education (12)
  • Enercon (1)
  • Enforcement (1)
  • EU (2)
  • ex parte (2)
  • exhaustion (3)
  • Exhaustion of Rights (2)
  • Fair Dealing (8)
  • Fair Use (11)
  • Federal Circuit (1)
  • Fees (3)
  • FICCI (7)
  • FRAND (2)
  • free trade agreement (3)
  • FTA (3)
  • G.I. Registry (4)
  • gene sequences (3)
  • Generic medicine (4)
  • Geographical Indication (14)
  • Gilead (1)
  • Glenmark (5)
  • Gopika (34)
  • Guest post (11)
  • guidelines (1)
  • GWU-CII (1)
  • Herceptin (1)
  • hot news (3)
  • ICANN (1)
  • incremental innovation (1)
  • independence (1)
  • india (5)
  • Indian Government (1)
  • Indian patent litigation (27)
  • Indian Pharma (35)
  • Injunction (10)
  • Innovation (7)
  • INTA (1)
  • Intermediaries (10)
  • internet (11)
  • Internet Access Providers (IAPs) (5)
  • Internet Censorship (7)
  • IP scholarship (3)
  • IP aware (4)
  • IP Course (3)
  • IP Education (1)
  • IP Policy (11)
  • IP update (4)
  • ip writing competition (1)
  • IPAB (34)
  • ipchair (1)
  • IPO (1)
  • IPRS (5)
  • IT Act (1)
  • Journal (2)
  • judicial independence (3)
  • Jurisdiction (1)
  • Kruttika (4)
  • Legal Education (3)
  • Legal Research Tools (1)
  • Legal Scholarship (2)
  • library (2)
  • Licensing (7)
  • Madhulika (20)
  • mathematical methods (1)
  • Media law (3)
  • medical method (1)
  • Merck (4)
  • mhrd ip chair (1)
  • Microsoft (3)
  • Middle Path (1)
  • Moral Rights (2)
  • Movies (18)
  • musical work (2)
  • nanotechnology (1)
  • Natco (3)
  • natco defamation suit (5)
  • natco vs bayer (4)
  • need for transparency (1)
  • Novartis (8)
  • Novartis patent case in India (11)
  • NPEs (2)
  • nujs (1)
  • NUJS Conference (2)
  • Obituary (1)
  • obviousness (7)
  • Off-Topic (2)
  • online course (4)
  • Open Access (6)
  • Open Source (2)
  • Opposition (3)
  • Parallel Imports (4)
  • Parliament (1)
  • passing off (5)
  • Patent (52)
  • Patent act (10)
  • patent agent (5)
  • patent agent exam (9)
  • patent agent exam qualifications (3)
  • patent infringement (5)
  • Patent Licensing (2)
  • Patent litigation (2)
  • Patent Office (19)
  • patent pool (3)
  • Patent Prosecution (7)
  • Patent rules (2)
  • Patent Strategies (8)
  • Patents (9)
  • pegasus (1)
  • Personality Rights (1)
  • Pfizer (1)
  • Pharma (18)
  • Piracy (5)
  • plagiarism (3)
  • Plant Variety Protection (2)
  • post grant (1)
  • Prashant (2)
  • Preventive Detention (1)
  • Price Control (6)
  • prior publication (1)
  • Privacy (3)
  • Prizes (1)
  • public health (3)
  • Public Interest (4)
  • Publicity Rights (4)
  • Publishing (3)
  • radio (2)
  • Rajiv (18)
  • Rectification Petition (2)
  • Rejection (1)
  • research (3)
  • reverse engineering (2)
  • revocation (4)
  • rip (1)
  • Roche (2)
  • Roche vs Cipla (1)
  • Royalty (2)
  • RTI (2)
  • Scholarship (4)
  • section 16 (1)
  • Section 3(d) (7)
  • section 8 (6)
  • shamnad (11)
  • Shan Kohli (4)
  • Shouvik Kumar Guha (30)
  • Smartphones/Tablets (2)
  • Social Innovation (1)
  • Software (10)
  • software enforcement (3)
  • software patent (3)
  • Special 301 Report (1)
  • Spicy Tidbits (6)
  • spicyip (1)
  • SpicyIP Accolades (1)
  • SpicyIP Announcements (9)
  • SpicyIP Case (1)
  • SpicyIP Cases (3)
  • spicyip commiseration (1)
  • SpicyIP Events (11)
  • SpicyIP Fellowship (5)
  • SpicyIP Guest Series (22)
  • SpicyIP Interview (2)
  • SpicyIP Jobs (4)
  • SpicyIP Jobs/General (2)
  • SpicyIP Review (1)
  • SpicyIP Tidbits (11)
  • SpicyIP Weekly Review (27)
  • Statutory Licensing (1)
  • STI Policy 2013 (4)
  • Sugen (3)
  • Supreme Court of India (5)
  • Swaraj (19)
  • Tarnishment (1)
  • Technology (6)
  • Technology Transfer (5)
  • TKDL (5)
  • TPP (1)
  • trade (4)
  • Trade Secret Protection (1)
  • Trademark (59)
  • Trademark dilution (1)
  • Trademark Registry (9)
  • Traditional Knowledge (7)
  • Transparency (5)
  • treaty (1)
  • trial (1)
  • tribunals (2)
  • TRIPS (11)
  • UK (3)
  • unfair competition (5)
  • UNFCCC (1)
  • Universities Research and Innovation Bill (2)
  • US (1)
  • US Patent Reform (1)
  • US Supreme Court (3)
  • viva (3)
  • WIPO (5)
  • Working a Patent (2)
  • Workshop (4)
  • writ (1)
  • WTO (1)

Blog Archive

  • ▼  2013 (364)
    • ►  September (13)
    • ►  August (41)
    • ►  July (36)
    • ►  June (36)
    • ▼  May (32)
      • Haldiram Bhujiawala: IPAB Order
      • Guest Post: Impugning novelty the Novartis way
      • Comparative Advertising: Reckitt Benckiser trumps ...
      • The (Great) Gatsby Files: IPAB decides in favour o...
      • SpicyIP Weekly Review (May 4th Week)
      • Comparative Advertising: Delhi HC (Reckitt Benckis...
      • Drug price control order (DPCO) 2013 : What's in s...
      • Micolube: Dual Protection and the Doctrine of Elec...
      • SpicyIP Tidbit: IPXI releases latest edition of i...
      • The Times Publishing House threatens to sue our bl...
      • Microsoft v. Motorola: A FRAND-ly formula for fixi...
      • Guest Post: A rejoinder from the IPKat
      • WIPS (Worldwide Intellectual Property Service) – I...
      • The curious case of medical method patent: Can doc...
      • Guest Post: A response to the IPKat's "despair" by...
      • Javed Akhtar nominated for CISAC Vice-Presidency
      • Guest Post: A quick update on Viacom v. YouTube
      • Guest post: Avoiding Open Source Surprises When Bu...
      • Guest Post: The IPKat's "despair" with the Supreme...
      • Comparative Advertising: Delhi HC (SAFFOLA v. FORT...
      • SpicyIP Events: Registrations for Consilience 2013...
      • IPAB upholds validity of Bajaj Auto's patent in re...
      • SpicyIP Tidbit: Update on Zanjeer and Bombay Talkies
      • The Ericsson-Micromax patent litigation: Where is ...
      • SpicyIP Weekly Review (May 2013, Week 1)
      • The Jaguar Trademark Conundrum
      • Social Innovations: A Braille Smartphone
      • USTR's Special 301 Process 2013 - India on Priorit...
      • The constitutional challenge by film producers to ...
      • FICCI announces online certificate course on compe...
      • Justice Sridevan’s status report to the Madras Hig...
      • Job openings at the Vidhi Centre for Legal Policy
    • ►  April (51)
    • ►  March (66)
    • ►  February (40)
    • ►  January (49)
  • ►  2012 (131)
    • ►  December (29)
    • ►  November (42)
    • ►  October (50)
    • ►  September (10)
Powered by Blogger.